<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Decision Modelling on data_fR@</title>
    <link>/tags/decision-modelling/</link>
    <description>Recent content in Decision Modelling on data_fR@</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Tue, 11 Jun 2019 00:00:00 +0000</lastBuildDate>
    
	<atom:link href="/tags/decision-modelling/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>Selecting an appropriate combination of drug dosages with R</title>
      <link>/post/selecting-appropriate-combination-of-drug-dosages-with-r/</link>
      <pubDate>Tue, 11 Jun 2019 00:00:00 +0000</pubDate>
      
      <guid>/post/selecting-appropriate-combination-of-drug-dosages-with-r/</guid>
      <description>Calculating appropriate drug costs is crucial for every health economic evaluation. I remember the first time I had to calculate drug costs. Back then, working with Microsoft Excel for a real project was excitingly new for me. However, I got quickly frustrated with this seemingly simple task. The price for a ‘simple’ dose of let’s say 125mg per patient can be calculated in different ways. Especially, when I had chose a combination from a plethora of smaller doses.</description>
    </item>
    
    <item>
      <title>Second‐line treatment for acute graft‐versus‐host disease with mesenchymal stromal cells: A decision model.</title>
      <link>/publication/gvhd-model/</link>
      <pubDate>Thu, 01 Nov 2018 00:00:00 +0200</pubDate>
      
      <guid>/publication/gvhd-model/</guid>
      <description>In this article we describe the development and simulation of a decision model for the second-line treatment of acute GvHD.</description>
    </item>
    
  </channel>
</rss>